Oncolys BioPharma, Inc.'s total assets for Q1 2025 were ¥2.31B, a decrease of -27.65% from the previous quarter. JP:4588 total liabilities were ¥373.88M for the fiscal quarter, a -16.29% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.